Skip to content

Medical-device intelligence

QEP: Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections

FDA product code QEP: Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QEP
FDA device name
Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections
Device class
2
Regulation number
866.3393
Medical specialty
Microbiology
Review panel
MI

FDA definition

A device to detect nucleic acids from non-viral microorganism(s) causing sexually transmitted infections is an in vitro diagnostic device intended for the detection and identification of nucleic acids from non-viral microorganism(s) in clinical specimens collected from patients suspected of sexually transmitted infections. The device is intended to aid in the diagnosis of non-viral sexually transmitted infections in conjunction with other clinical and laboratory data.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

23 clearance records and 4 recall records in the covered releases, across 12 source company names and 1 product codes. Dated history runs from May 22, 2019 to Jul 8, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202620
June 202600
July 202610
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

27 matching records
Device / recordCompany in FDA recordSourceSource date
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systemsK260917 · QEPRoche Molecular Systems, Inc.510(k)Jul 8, 2026FDA decision date
cobas liat CT/NG nucleic acid testK253756 · QEPRoche Molecular Systems, Inc.510(k)May 15, 2026FDA decision date
cobas liat CT/NG/MG nucleic acid testK253759 · QEPRoche Molecular Systems, Inc.510(k)May 15, 2026FDA decision date
Visby Medical Men's Sexual Health TestK251501 · QEPVisby Medical, Inc.510(k)Oct 1, 2025FDA decision date
BD CTGCTV2K243343 · QEPBd Integrated Diagnostic Solutions/Becton,510(k)Apr 22, 2025FDA decision date
cobas® liat CT/NG nucleic acid testK240217 · QEPRoche Molecular Systems, Inc.510(k)Jan 17, 2025FDA decision date
cobas® liat CT/NG/MG nucleic acid testK240197 · QEPRoche Molecular Systems, Inc.510(k)Jan 16, 2025FDA decision date
BD COR MX Instrument Version or Model: 443989 Catalog Number: 443989Z-0588-2025 · QEPBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
BD COR GX Instrument Version or Model: 443990 Catalog Number: 443990Z-0589-2025 · QEPBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
Abbott Alinity m STI AMP Kit, used with the Alinity m System, product codes: a) REF 09N17-095; b) REF 09N17-090; c) REF 09N17-091;Z-0234-2025 · QEPAbbott Molecular, Inc.RecallOct 29, 2024FDA classification date
NeuMoDx CT/NG Assay 2.0K230267 · QEPNeumodx Molecular, Inc.510(k)Dec 22, 2023FDA decision date
binx io CT/NG Assay- Single-use Cartridge for the qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae Ref: 1.002.101Z-1626-2023 · QEPBinx Health, Inc.RecallMay 23, 2023FDA classification date
Visby Medical Sexual Health TestK220407 · QEPVisby Medical510(k)Mar 7, 2023FDA decision date
Alinity m STI AssayK222379 · QEPAbbott Molecular, Inc.510(k)Mar 3, 2023FDA decision date
Aptima Combo 2 Assay (250 test kit) Panther, Aptima Combo 2 Assay (250 test kit) Tigris, Aptima Trichomonas Vaginalis Assay (250 test kit) Panthe…K220321 · QEPHologic, Inc.510(k)Jun 3, 2022FDA decision date
BD CTGCTV2K210585 · QEPBecton, Dickinson and Company510(k)May 10, 2022FDA decision date
Alinity m STI AssayK202977 · QEPAbbott Molecular, Inc.510(k)Apr 29, 2022FDA decision date
Rheonix STI TriPlex Assay, Rheonix EncompassMDx Workstation (instrument and software), Rheonix Urine Specimen Collection KitK193081 · QEPRheonix, Inc.510(k)Dec 17, 2021FDA decision date
Visby Medical Sexual HealthK200748 · QEPVisby Medical510(k)Aug 26, 2021FDA decision date
cobas CTNG for use on cobas 6800/8800 systemsK202408 · QEPRoche Molecular Systems, Inc.510(k)Jan 21, 2021FDA decision date
Aptima Combo 2 Assay (Panther System), Aptima Combo 2 Assay (Tigris) System)K200866 · QEPHologic, Inc.510(k)May 17, 2020FDA decision date
binx io CT/NG Assay and binx io CT/NG SystemK200533 · QEPBinx Health, Inc.510(k)Apr 27, 2020FDA decision date
Aptima Combo 2 Assay (Panther) - 250 test kit, Aptima Combo 2 Assay (Tigris) - 250 test kit, Aptima Trichomonas Vaginalis (Panther) - 250 test ki…K200436 · QEPHologic, Inc.510(k)Mar 23, 2020FDA decision date
binx health io CT/NG AssayK191352 · QEPBinx Health, Inc.510(k)Aug 8, 2019FDA decision date
Xpert CT/NG, GeneXpert Dx System, GeneXpert Infinity-48s and GeneXpert Infinity-80 Systems, GeneXpert Infinity-48 System, Xpert Vaginal/Endocervi…K190441 · QEPCepheid510(k)May 23, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗